At a glance
ClinicalIndex Comparison RecordN/ACompleted· 55 enrolled
Drug / intervention
mLCI Devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Coherence Imaging of the Cervical Epithelium
In Brief
A clinical study evaluating mLCI Device for Cervical Epithelia. Completed, enrolled 55 participants across 1 site.
Detailed Summary
The purpose of this study is to develop a multiplexed low coherence interferometry (mLCI) endoscopic probe for mapping the epithelial types of the cervix. This vaginal mLCI probe will obtain optical measurements from the cervix. These measurements can be used to create a map of the surface cells that distinguishes ectocervical epithelia, endocervical epithelia, and the squamocolumnar junction (t-zone), which is the region where cervical dysplasia is most likely to occur.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCervical Epithelia
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI), Jacobi Medical Center
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedSep 2016
Enrollment StartOct 2016
Primary CompletionOct 2017
TodayJul 2026
First PostedSep 16, 2016
Enrollment StartOct 27, 2016
Primary CompletionOct 24, 2017
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 9.8 years ago
Interventions
mLCI Devicedevice
imaging of cervical epithelium using mLCI device